How to read this section: We test whether three price-based signals —
12-month momentum (trailing stock return), realized volatility (annualized standard deviation of daily returns), and
relative strength (stock return minus S&P 500 return) — predict next-quarter fundamental outcomes:
revenue growth, operating margin change, and ROE change (all year-over-year to remove seasonality).
Each cell shows the Pearson correlation (r) between signal at quarter Q and outcome at quarter Q+1.
Values closer to +1 or −1 indicate stronger predictive relationships. “n” is the number of quarterly observations.
The examination of price-derived signals for U.S. Physical Therapy, Inc. (USPH) over a 45‑quarter window reveals an absence of robust predictive relationships between market dynamics and subsequent fundamental performance. The strongest observed correlation is a modest positive link between the 12‑month momentum indicator and revenue growth (r=0.348, p=0.026, n=41), which reaches statistical significance at the 5% level but falls below the conventional threshold for a notable effect (|r|≥0.4). All other examined pairings—momentum with margin or ROE change, realized volatility with any fundamental metric, and relative strength with any outcome—display weak correlations (|r|≤0.232) and lack statistical significance (p>0.10). Consequently, the data do not support a consistent narrative that price momentum, volatility, or relative strength reliably forecast USPH’s operational results in the near term.
12M Momentum correlates with Revenue Growth at r=0.348 (p=0.026, n=41), achieving statistical significance but remaining below the notable threshold (|r|≥0.4).
All volatility‑related signals show weak and non‑significant links to fundamentals (e.g., Realized Volatility vs. Revenue Growth r=-0.232, p=0.145).
Relative Strength exhibits no meaningful predictive power for any of the three outcomes (largest |r|=0.144, p>0.36).
No cross‑company patterns emerge; USPH is the only firm analyzed and it presents no consistent predictive signals.
Limitations: The sample size of 41 quarterly observations limits statistical power and may inflate Type I errors. Correlations do not imply causation; observed links could be driven by omitted variables or broader market regimes. Signal effectiveness may be regime‑dependent, and the analysis does not account for structural breaks such as COVID‑19 disruptions.
USPH
For USPH, the sole statistically significant relationship is between 12‑month price momentum and revenue growth (r=0.348, p=0.026, n=41). This modest correlation suggests that periods of upward price drift may coincide with subsequent top‑line expansion, possibly reflecting market participants anticipating improved demand for physical therapy services or the incorporation of early earnings guidance into equity prices. However, the effect size is below the notable threshold, indicating limited practical forecasting power. All other signal–outcome pairs—momentum versus margin change (r=-0.064) and ROE change (r=-0.080), realized volatility versus revenue growth (r=-0.232), margin change (r=0.231), ROE change (r=-0.102), and relative strength versus any metric—are weak, statistically insignificant, and lack a clear economic rationale, underscoring the difficulty of extracting forward‑looking insight from these price measures for this business.